LX 1606 Hippurate 5mg 5mg | Purity Not Available
Adooq Bioscience
LX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLuteolin is a PDE4 inhibitor, phosphodiesterase inhibitor, and an interleukin 6 inhibitor, affecting xylazine/ketamine-induced anesthesia in mice. Luteolin acts as a monoamine transporter activator, and is one of the few chemicals demonstrated to possess this property.
More Information Supplier PageLuteolin is a PDE4 inhibitor, phosphodiesterase inhibitor, and an interleukin 6 inhibitor, affecting xylazine/ketamine-induced anesthesia in mice. Luteolin acts as a monoamine transporter activator, and is one of the few chemicals demonstrated to possess this property.
More Information Supplier PageLY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments.
More Information Supplier PageLY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments.
More Information Supplier PageLY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity.
More Information Supplier PageLY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity.
More Information Supplier Page